Zoetis Inc. (NYSE:ZTS) Stock Holdings Cut by In Depth Partners LLC

In Depth Partners LLC lowered its holdings in shares of Zoetis Inc. (NYSE:ZTS) by 40.9% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 33,728 shares of the company’s stock after selling 23,360 shares during the quarter. Zoetis makes up 6.8% of In Depth Partners LLC’s holdings, making the stock its 7th largest position. In Depth Partners LLC’s holdings in Zoetis were worth $6,590,000 as of its most recent SEC filing.

Other hedge funds also recently bought and sold shares of the company. Integrated Wealth Concepts LLC raised its holdings in shares of Zoetis by 1.3% during the third quarter. Integrated Wealth Concepts LLC now owns 7,271 shares of the company’s stock valued at $1,421,000 after acquiring an additional 92 shares during the last quarter. Investment Management Corp of Ontario raised its holdings in shares of Zoetis by 176.9% during the third quarter. Investment Management Corp of Ontario now owns 40,589 shares of the company’s stock valued at $7,930,000 after acquiring an additional 25,931 shares during the last quarter. Hilltop Holdings Inc. raised its holdings in shares of Zoetis by 1,282.0% during the third quarter. Hilltop Holdings Inc. now owns 38,944 shares of the company’s stock valued at $7,609,000 after acquiring an additional 36,126 shares during the last quarter. Holocene Advisors LP acquired a new position in shares of Zoetis during the third quarter valued at approximately $110,809,000. Finally, Beacon Investment Advisory Services Inc. raised its holdings in shares of Zoetis by 0.8% during the third quarter. Beacon Investment Advisory Services Inc. now owns 143,944 shares of the company’s stock valued at $28,124,000 after acquiring an additional 1,155 shares during the last quarter. Hedge funds and other institutional investors own 92.80% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on the company. Argus raised Zoetis to a “strong-buy” rating in a report on Friday, August 9th. BTIG Research increased their price target on Zoetis from $220.00 to $225.00 and gave the company a “buy” rating in a report on Monday, August 12th. Stifel Nicolaus increased their price target on Zoetis from $200.00 to $210.00 and gave the company a “buy” rating in a report on Wednesday, September 18th. JPMorgan Chase & Co. increased their price target on Zoetis from $225.00 to $230.00 and gave the company an “overweight” rating in a report on Friday, October 11th. Finally, Leerink Partnrs raised Zoetis to a “strong-buy” rating in a report on Monday. Eleven analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Buy” and an average target price of $220.80.

Zoetis Trading Up 0.0 %

Shares of ZTS traded up $0.06 during midday trading on Tuesday, hitting $176.87. 83,994 shares of the stock were exchanged, compared to its average volume of 2,534,198. Zoetis Inc. has a 52-week low of $144.80 and a 52-week high of $201.92. The stock has a fifty day simple moving average of $183.83 and a 200 day simple moving average of $180.97. The firm has a market cap of $79.80 billion, a P/E ratio of 33.24, a P/E/G ratio of 2.69 and a beta of 0.89. The company has a debt-to-equity ratio of 1.26, a quick ratio of 2.27 and a current ratio of 3.69.

Zoetis (NYSE:ZTS) last released its earnings results on Monday, November 4th. The company reported $1.58 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.46 by $0.12. The firm had revenue of $2.40 billion during the quarter, compared to analyst estimates of $2.29 billion. Zoetis had a return on equity of 51.98% and a net margin of 26.55%. Zoetis’s revenue was up 11.6% compared to the same quarter last year. During the same period last year, the business posted $1.36 earnings per share. On average, research analysts anticipate that Zoetis Inc. will post 5.9 EPS for the current fiscal year.

Zoetis Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 3rd. Investors of record on Thursday, October 31st will be issued a $0.432 dividend. The ex-dividend date of this dividend is Thursday, October 31st. This represents a $1.73 dividend on an annualized basis and a yield of 0.98%. Zoetis’s dividend payout ratio (DPR) is presently 32.52%.

Zoetis Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.